Βιλαζοδόνη

Vilazodone is classified as Antidepressant (SSRI + 5‑HT1A partial agonist). It belongs to the Indole-derived benzofuran; serotonergic antidepressant chemical class.

Also known as: Vilazodone hcl, Viibryd, EMD-68843, SB-659746A

Classification

Chemical: Medicine
Psychoactive: Depressant

Effects

Nausea
Headache
Insomnia
Sleep Fragmentation
Sedation
Motor Impairment
Mood Improvement In Depressed Individuals
Anxiety Suppression
Vivid Dreams
Reduced Anxiety
Sexual Dysfunction
Dulled Perception

Routes of Administration

Oral

Dosage

Heavy: >40 mg (not recommended)
Light: 10-20 mg
Common: 20-40 mg
Strong: 40 mg
Threshold: 5 mg

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

openFDA.gov

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu